Plavix Sales Data
Last updated: February 2014 (updated quarterly).
The following data shows Plavix U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q2 2012 | 9 ( 8) |
$934,731 | -42.33% | 3,070 | -41.53% |
| Q1 2012 | 1 ( 1) |
$1,620,790 | 2.85% | 5,251 | 0.23% |
| Q4 2011 | 2 | $1,575,841 | -3.38% | 5,239 | -1.49% |
| Q3 2011 | 2 | $1,630,951 | -3.97% | 5,318 | -2.58% |
| Q2 2011 | 2 | $1,698,357 | 2.61% | 5,459 | -0.18% |
| Q1 2011 | 2 | $1,655,111 | n/a | 5,469 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
